MRI tracking of FePro labeled fresh and cryopreserved long term in vitro expanded human cord blood AC133+ endothelial progenitor cells in rat glioma

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Janic, Branislava ^a   Jafari Khouzani, Kourosh ^a,b   Babajani Feremi, Abbas ^a   Iskander, A S M ^a   Varma, Nadimpalli Ravi S ^a   Ali, Meser M ^a   Knight, Robert A ^a   Arbab, Ali S ^a  

^a HENRY FORD HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERUMOXIDE PROTAMINE SULFATE; PROTAMINE SULFATE; SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; CELL MIGRATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORD BLOOD AC133+ ENDOTHELIAL PROGENITOR CELL; CRYOPRESERVATION; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; FLUORESCENCE MICROSCOPY; GLIOMA; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IMPLANTATION; IN VITRO STUDY; IN VIVO STUDY; MONITORING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RAT; UMBILICAL CORD BLOOD;

ANIMALS; ANTIGENS, CD; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL MOVEMENT; CELL TRACKING; CELLS, CULTURED; CONTRAST MEDIA; CRYOPRESERVATION; DEXTRANS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FETAL BLOOD; GLIOMA; GLYCOPROTEINS; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; NEOVASCULARIZATION, PHYSIOLOGIC; PEPTIDES; PRIMARY CELL CULTURE; PROTAMINES; RATS; RATS, NUDE; STAINING AND LABELING; STEM CELL TRANSPLANTATION; STEM CELLS;

ANIMALIA; RATTUS;

EID: 84861475269     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037577     Document Type: Article

References (72)

1. Scott SM, Barth MG, Gaddy LR, Ahl ET Jr, (1994) The role of circulating cells in the healing of vascular prostheses. J Vasc Surg 19: 585-593.
2. Solovey A, Lin Y, Browne P, Choong S, Wayner E, et al. (1997) Circulating activated endothelial cells in sickle cell anemia. N Engl J Med 337: 1584-1590.
3. Sowemimo-Coker SO, Meiselman HJ, Francis RB Jr, (1989) Increased circulating endothelial cells in sickle cell crisis. Am J Hematol 31: 263-265.
4. Hladovec J, (1978) Circulating endothelial cells as a sign of vessel wall lesions. Physiol Bohemoslov 27: 140-144.
5. Hladovec J, Prerovsky I, Stanek V, Fabian J, (1978) Circulating endothelial cells in acute myocardial infarction and angina pectoris. Klin Wochenschr 56: 1033-1036.
6. Watt SM, Athanassopoulos A, Harris AL, Tsaknakis G, (2010) Human endothelial stem/progenitor cells, angiogenic factors and vascular repair. Journal of The Royal Society Interface 7: S731-S751.
7. Richardson MR, Yoder MC, (2010) Endothelial progenitor cells: Quo Vadis? J Mol Cell Cardiol.
8. Yoder MC, (2010) Is endothelium the origin of endothelial progenitor cells? Arterioscler Thromb Vasc Biol 30: 1094-1103.
9. Khakoo AY, Finkel T, (2005) Endothelial progenitor cells. Annu Rev Med 56: 79-101.
10. Miraglia S, Godfrey W, Yin AH, Atkins K, Warnke R, et al. (1997) A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 90: 5013-5021.
11. Yin AH, Miraglia S, Zanjani ED, Almeida-Porada G, Ogawa M, et al. (1997) AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 90: 5002-5012.
12. Fujiyama S, Amano K, Uehira K, Yoshida M, Nishiwaki Y, et al. (2003) Bone marrow monocyte lineage cells adhere on injured endothelium in a monocyte chemoattractant protein-1-dependent manner and accelerate reendothelialization as endothelial progenitor cells. Circ Res 93: 980-989.
13. Bhattacharya V, McSweeney PA, Shi Q, Bruno B, Ishida A, et al. (2000) Enhanced endothelialization and microvessel formation in polyester grafts seeded with CD34 (+) bone marrow cells. Blood 95: 581-585.
14. Gehling UM, Ergun S, Schumacher U, Wagener C, Pantel K, et al. (2000) In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 95: 3106-3112.
15. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, et al. (2003) Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348: 593-600.
16. Hu Y, Davison F, Zang Z, Xu Q, (2003) Endothelial replacement and angiogenesis in arteriosclerotic lesions of allografts are contributed by circulating progenitor cells. Circulation 108: 3122-3127.
17. Hur J, Yoon CH, Lee CS, Kim TY, Oh IY, et al. (2007) Akt is a key modulator of endothelial progenitor cell trafficking in ischemic muscle. Stem Cells 25: 1769-1778.
18. Askari AT, Unzek S, Popovic ZB, Goldman CK, Forudi F, et al. (2003) Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 362: 697-703.
19. Kawamoto A, Gwon HC, Iwaguro H, Yamaguchi JI, Uchida S, et al. (2001) Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 103: 634-637.
20. Navarro-Sobrino M, Rosell A, Hernandez-Guillamon M, Penalba A, Ribó M, et al. (2010) Mobilization, endothelial differentiation and functional capacity of endothelial progenitor cells after ischemic stroke. Microvascular Research In Press, Corrected Proof.
21. Rad AM, Iskander AS, Janic B, Knight RA, Arbab AS, et al. (2009) AC133+ progenitor cells as gene delivery vehicle and cellular probe in subcutaneous tumor models: a preliminary study. BMC Biotechnol 9: 28.
22. Arbab AS, Janic B, Knight RA, Anderson SA, Pawelczyk E, et al. (2008) Detection of migration of locally implanted AC133+ stem cells by cellular magnetic resonance imaging with histological findings. FASEB J 22: 3234-3246.
23. Varma NR, Janic B, Iskander AS, Shankar A, Bhuiyan MP, et al. (2012) Endothelial Progenitor Cells (EPCs) as Gene Carrier System for Rat Model of Human Glioma. PLoS ONE 7: e30310.
24. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, et al. (2004) Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10: 858-864.
25. Isner JM, Asahara T, (1999) Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J Clin Invest 103: 1231-1236.
26. Banai S, Shweiki D, Pinson A, Chandra M, Lazarovici G, et al. (1994) Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis. Cardiovasc Res 28: 1176-1179.
27. Carmeliet P, Jain RK, (2000) Angiogenesis in cancer and other diseases. Nature 407: 249-257.
28. Urbich C, Dimmeler S, (2004) Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 95: 343-353.
29. Janic B, Rad AM, Jordan EK, Iskander AS, Ali MM, et al. (2009) Optimization and validation of FePro cell labeling method. PLoS One 4: e5873.
30. Katayama Y, Yano T, Bessho A, Deguchi S, Sunami K, et al. (1997) The effects of a simplified method for cryopreservation and thawing procedures on peripheral blood stem cells. Bone Marrow Transplant 19: 283-287.
31. Arbab AS, Yocum GT, Kalish H, Jordan EK, Anderson SA, et al. (2004) Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood 104: 1217-1223.
32. Janic B, Guo AM, Iskander ASM, Varma NRS, Scicli AG, et al. (2010) Human Cord Blood-Derived AC133+ Progenitor Cells Preserve Endothelial Progenitor Characteristics after Long Term In Vitro Expansion. PLoS ONE 5: e9173.
33. Ma G, Lin XX, Jin YB, Li W, Wang W, et al. (2008) [Isolation, culture and characterization of endothelial cells in infantile hemangioma]. Zhonghua Zheng Xing Wai Ke Za Zhi 24: 144-147.
34. Werner C, Bohm M, Friedrich EB, (2008) Role of integrin-linked kinase for functional capacity of endothelial progenitor cells in patients with stable coronary artery disease. Biochem Biophys Res Commun 377: 331-336.
35. Eggermann J, Kliche S, Jarmy G, Hoffmann K, Mayr-Beyrle U, et al. (2003) Endothelial progenitor cell culture and differentiation in vitro: a methodological comparison using human umbilical cord blood. Cardiovasc Res 58: 478-486.
36. Gross P, Herbrig K, (2004) Role of endothelial progenitor cells in cardiovascular pathology. Rocz Akad Med Bialymst 49: 174-177.
37. Lee OK, Kuo TK, Chen WM, Lee KD, Hsieh SL, et al. (2004) Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 103: 1669-1675.
38. Moise KJ Jr, (2005) Umbilical cord stem cells. Obstet Gynecol 106: 1393-1407.
39. Kogler G, Sensken S, Airey JA, Trapp T, Muschen M, et al. (2004) A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med 200: 123-135.
40. Fibbe WE, Noort WA, Schipper F, Willemze R, (2001) Ex vivo expansion and engraftment potential of cord blood-derived CD34+ cells in NOD/SCID mice. Ann N Y Acad Sci 938: 9-17.
41. Hao QL, Shah AJ, Thiemann FT, Smogorzewska EM, Crooks GM, (1995) A functional comparison of CD34 + CD38- cells in cord blood and bone marrow. Blood 86: 3745-3753.
42. Senegaglia AC, Brofman PR, Aita CA, Dallagiovanna B, Rebelatto CL, et al. (2008) In vitro formation of capillary tubules from human umbilical cord blood cells with perspectives for therapeutic application. Rev Bras Cir Cardiovasc 23: 467-473.
43. McGuckin CP, Forraz N, (2008) Potential for access to embryionic-like cells from human umbilical cord blood. Cell Prolif 41: 31-40.
44. Yao C-L, Feng Y-H, Lin X-Z, Chu I-M, Hsieh T-B, et al. (2006) Characterization of Serum-Free Ex Vivo-Expanded Hematopoietic Stem Cells Derived from Human Umbilical Cord Blood CD133+ Cells. Stem Cells and Development 15: 70-78.
45. Gammaitoni L, Weisel KC, Gunetti M, Wu K-D, Bruno S, et al. (2004) Elevated telomerase activity and minimal telomere loss in cord blood long-term cultures with extensive stem cell replication. Blood 103: 4440-4448.
46. Yossi C, Arnon N, (2004) Umbilical cord blood transplantation-how, when and for whom? Blood reviews 18: 167-179.
47. Rocha V, Wagner JE, Sobocinski KA, Klein JP, Zhang M-J, et al. (2000) Graft-Versus-Host Disease in Children Who Have Received a Cord-Blood or Bone Marrow Transplant from an HLA-Identical Sibling. N Engl J Med 342: 1846-1854.
48. Scheubel RJ, Zorn H, Silber RE, Kuss O, Morawietz H, et al. (2003) Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol 42: 2073-2080.
49. Goldberg JL, Laughlin MJ, Pompili VJ, (2007) Umbilical cord blood stem cells: implications for cardiovascular regenerative medicine. J Mol Cell Cardiol 42: 912-920.
50. Woods EJ, Pollok KE, Byers MA, Perry BC, Purtteman J, et al. (2007) Cord Blood Stem Cell Cryopreservation. Transfusion Medicine and Hemotherapy 34: 276-285.
51. Suzanne MW, Marcela C, (2005) Stem cell medicine: Umbilical cord blood and its stem cell potential. Seminars in fetal & neonatal medicine 10: 209-220.
52. Yang C, Zhang ZH, Li ZJ, Yang RC, Qian GQ, et al. (2004) Enhancement of neovascularization with cord blood CD133+ cell-derived endothelial progenitor cell transplantation. Thromb Haemost 91: 1202-1212.
53. Bonanno G, Mariotti A, Procoli A, Corallo M, Rutella S, et al. (2007) Human cord blood CD133+ cells immunoselected by a clinical-grade apparatus differentiate in vitro into endothelial- and cardiomyocyte-like cells. Transfusion 47: 280-289.
54. Kuci S, Kuci Z, Schmid S, Seitz G, Muller I, et al. (2008) Efficient in vitro generation of adult multipotent cells from mobilized peripheral blood CD133+ cells. Cell Prolif 41: 12-27.
55. Timmermans F, Plum J, Yoder MC, Ingram DA, Vandekerckhove B, et al. (2008) Endothelial progenitor cells: Identity defined? J Cell Mol Med.
56. Young PP, Vaughan DE, Hatzopoulos AK, (2007) Biologic properties of endothelial progenitor cells and their potential for cell therapy. Prog Cardiovasc Dis 49: 421-429.
57. Dong C, Goldschmidt-Clermont PJ, (2007) Endothelial progenitor cells: a promising therapeutic alternative for cardiovascular disease. J Interv Cardiol 20: 93-99.
58. Fraisl P, Mazzone M, Schmidt T, Carmeliet P, (2009) Regulation of angiogenesis by oxygen and metabolism. Dev Cell 16: 167-179.
59. Kawamoto A, Tkebuchava T, Yamaguchi J, Nishimura H, Yoon YS, et al. (2003) Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation 107: 461-468.
60. Terranova VP, DiFlorio R, Lyall RM, Hic S, Friesel R, et al. (1985) Human endothelial cells are chemotactic to endothelial cell growth factor and heparin. J Cell Biol 101: 2330-2334.
61. Arbab AS, Pandit SD, Anderson SA, Yocum GT, Bur M, et al. (2006) Magnetic resonance imaging and confocal microscopy studies of magnetically labeled endothelial progenitor cells trafficking to sites of tumor angiogenesis. Stem Cells 24: 671-678.
62. Rafat N, Beck G, Schulte J, Tuettenberg J, Vajkoczy P, (2010) Circulating endothelial progenitor cells in malignant gliomas. J Neurosurg 112: 43-49.
63. Anderson SA, Glod J, Arbab AS, Noel M, Ashari P, et al. (2005) Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model. Blood 105: 420-425.
64. Anderson SA, Shukaliak-Quandt J, Jordan EK, Arbab AS, Martin R, et al. (2004) Magnetic resonance imaging of labeled T-cells in a mouse model of multiple sclerosis. Ann Neurol 55: 654-659.
65. Arbab AS, Jordan EK, Wilson LB, Yocum GT, Lewis BK, et al. (2004) In vivo trafficking and targeted delivery of magnetically labeled stem cells. Hum Gene Ther 15: 351-360.
66. Hoehn M, Kustermann E, Blunk J, Wiedermann D, Trapp T, et al. (2002) Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc Natl Acad Sci U S A 99: 16267-16272.
67. Yokomuro H, Shiono N, Ozawa T, Fujii T, Watanabe Y, et al. (2010) Effect of Cryopreservation on Cell Proliferation and Immunogenicity of Transplanted Human Heart Cells. Ann Thorac Cardiovasc Surg 16.
68. Broxmeyer HE, (2008) Cord blood hematopoietic stem cell transplantation.
69. Alencar S, Garnica M, Luiz RR, Nogueira CM, Borojevic R, et al. (2010) Cryopreservation of peripheral blood stem cell: the influence of cell concentration on cellular and hematopoietic recovery. Transfusion 50: 2402-2412.
70. Zeisberger SM, Schulz JC, Mairhofer M, Ponsaerts P, Wouters G, et al. (2010) Biological and physicochemical characterization of a serum- and xeno-free chemically defined cryopreservation procedure for adult human progenitor cells. Cell Transplant.
71. Rubinstein P, Dobrila L, Rosenfield RE, Adamson JW, Migliaccio G, et al. (1995) Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci U S A 92: 10119-10122.
72. Sputtek A, Horn EP, Schulte Am Esch J, Kuhnl P, (2001) [Cryopreservation of red blood cells using hydroxyethyl starch (HES)-From laboratory investigations to clinical application]. Anasthesiol Intensivmed Notfallmed Schmerzther 36 (Suppl 2): S162-164.